| # | Drug | Count |
|---|---|---|
| 0 | LEVOCETIRIZINE DIHYDROCHLORIDE | 2 |
| 1 | ADALIMUMAB | 1 |
| 2 | ALPRAZOLAM | 1 |
| 3 | AMLODIPINE BESYLATE | 1 |
| 4 | ASPIRIN | 1 |
| 5 | ASPIRIN 325 MG | 1 |
| 6 | ASPIRIN 81 MG | 1 |
| 7 | BELIMUMAB | 1 |
| 8 | DANAZOL | 1 |
| 9 | ETANERCEPT | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DANAZOL | 1 | 0.0004 |
| 1 | ICATIBANT ACETATE | 1 | 0.0002 |
| 2 | REGORAFENIB | 1 | 0.0001 |
| 3 | LEVOCETIRIZINE DIHYDROCHLORIDE | 2 | 0.0001 |
| 4 | PANITUMUMAB | 1 | 0.0001 |
| 5 | BELIMUMAB | 1 | 0.0000 |
| 6 | IXEKIZUMAB | 1 | 0.0000 |
| 7 | MELOXICAM | 1 | 0.0000 |
| 8 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 9 | FLUOROURACIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 1 | 0.0000 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Anti-IgE [EPC] | 1 | 0.0000 |
| 5 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 6 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 7 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Progestin [EPC] | 1 | 0.0000 |